QZ Probe Protease Activity Detection in Biological Samples
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for assessing protease activity in biological samples are not robust or reliable, as they often fail to distinguish between active and inactive forms of proteases or those complexed with inhibitors, and can be affected by ex vivo proteolysis and denaturation during analysis.
Innovation Solution
A method using a quantitative zymography (QZ) probe comprising a bipartite polypeptide with a cleavable linker, where the probe is contacted with a biological sample, incubated, and the resulting analytes measured to determine protease activity, allowing for the differentiation of intact, activated, and complexed proteases.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If standard zymography is used to directly measure protease activity through substrate conversion, then protease activity can be detected, but tissue homogenization may cause aberrant ex vivo proteolysis and proteases may be denatured during electrophoresis
Solution Approach 1:
The patent applies preliminary action by pre-incubating tissue sections with protease inhibitors before zymography to prevent aberrant ex vivo proteolysis. This pre-treatment step addresses the reliability issue by eliminating unwanted proteolytic activity that would occur during sample preparation, ensuring that only physiological protease activity is measured.
Solution Approach 2:
The patent uses in situ zymography on tissue sections as a copy or representation of the actual tissue protease activity state, avoiding the need for homogenization. This approach preserves the native tissue architecture and prevents denaturation, allowing accurate measurement of protease activity in its physiological context.
2Quantity of substance
If mRNA quantification or immunoassays are used to measure protease expression levels, then protease quantity can be determined, but active and inactive forms cannot be distinguished
Solution Approach 1:
The patent applies local quality by using substrate-specific probes that target particular protease types (e.g., gelatin for MMPs, casein for cathepsins). This allows differentiation of active proteases based on their specific substrate cleavage activity, providing both quantity and functional status information rather than just total expression levels.
Solution Approach 2:
The patent employs colorimetric or fluorometric substrates that change optical properties upon cleavage by active proteases. This enables direct visualization and quantification of protease activity, distinguishing active from inactive forms through detectable signal changes rather than relying on antibody binding to total protein.
3Ease of manufacture
If in situ zymography with broad-spectrum dye-quenched substrates is used, then protease activity can be visualized, but the method lacks robustness and wide applicability
Solution Approach 1:
The patent applies parameter changes by optimizing incubation conditions, substrate concentrations, and detection parameters for different tissue types and protease targets. This systematic optimization across multiple parameters enhances method robustness and reliability, making the assay widely applicable while maintaining simplicity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides a robust and reliable method for estimating physiological and pathological protease activity levels, enabling accurate measurement of protease activity in various biological samples, including tissues and bodily fluids.
Implementation Method 1
Proteases, or proteolytic enzymes, catalyze the breakdown of proteins by hydrolysis of peptide bonds
Data Source
AI summary
A method of determining protease activity in a biological sample comprising: (a) contacting the biological sample with a solution comprising a QZ probe to form a mixture; (b) incubating the mixture, thereby forming an incubated mixture comprising an incubated liquid; and (c) measuring the quantity of one or more analytes in a sample of the incubated liquid to determine the level of protease activity in the biological sample.